Department of Vascular Rehabilitation, San Giovanni Battista Hospital, Rome, Italy.
Research Unit, MAGI Euregio, Bolzano, Italy.
J Med Genet. 2018 Apr;55(4):222-232. doi: 10.1136/jmedgenet-2017-105064. Epub 2018 Feb 9.
Syndromes with lymphatic malformations show phenotypic variability within the same entity, clinical features that overlap between different conditions and allelic as well as heterogeneity. The aim of this review is to provide a comprehensive clinical genetic description of lymphatic malformations and the techniques used for their diagnosis, and to propose a flowchart for genetic testing. Literature and database searches were performed to find conditions characterised by lymphatic malformations or the predisposition to lymphedema after surgery, to identify the associated genes and to find the guidelines and genetic tests currently used for the molecular diagnosis of these disorders. This search allowed us to identify several syndromes with lymphatic malformations that are characterised by a great heterogeneity of phenotypes, alleles and , and a high frequency of sporadic cases, which may be associated with somatic mutations. For these disorders, we found many diagnostic tests, an absence of harmonic guidelines for molecular diagnosis and well-established clinical guidelines. Targeted sequencing is the preferred method for the molecular diagnosis of lymphatic malformations. These techniques are easy to implement and have a good diagnostic success rates. In addition, they are relatively inexpensive and permit parallel analysis of all known disease-associated genes. The targeted sequencing approach has improved the diagnostic process, giving patients access to better treatment and, potentially, to therapy personalised to their genetic profiles. These new techniques will also facilitate the prenatal and early postnatal diagnosis of congenital lymphatic conditions and the possibility of early intervention.
淋巴管畸形相关综合征在同一实体中表现出表型变异性,不同病症之间存在临床特征重叠,以及等位基因和遗传异质性。本综述旨在提供淋巴管畸形的全面临床遗传学描述,以及用于其诊断的技术,并提出遗传检测的流程图。通过文献和数据库搜索,寻找以淋巴管畸形或手术后淋巴水肿易感性为特征的病症,以确定相关基因,并找到目前用于这些疾病分子诊断的指南和遗传检测。这项搜索使我们能够识别出几种淋巴管畸形综合征,其表型、等位基因和遗传异质性很大,散发病例频率较高,可能与体细胞突变有关。对于这些疾病,我们发现了许多诊断测试,但缺乏分子诊断的协调指南和完善的临床指南。靶向测序是淋巴管畸形分子诊断的首选方法。这些技术易于实施,且具有较高的诊断成功率。此外,它们相对便宜,并且可以并行分析所有已知与疾病相关的基因。靶向测序方法改善了诊断过程,使患者能够获得更好的治疗,并且可能根据其遗传特征进行个性化治疗。这些新技术还将促进先天性淋巴疾病的产前和产后早期诊断,以及早期干预的可能性。